PCLO Share Price | PharmaCielo Ltd. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

1.1 k

Shareholding (Sep 2025)

FII

0.20%

Held by 1 FIIs

DII

99.8%

Held by 0 DIIs

Promoter

0.00%

Compare PharmaCielo Ltd. with Similar Stocks

MediPharm Labs Corp.CanadaBis Capital, Inc.Leef Brands, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

Poor long term growth as Operating profit has grown by an annual rate 13.16% of over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times

Flat results in Dec 24

Risky -

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Other Agricultural Products

Market cap

CAD 20 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-1.18

Return on Equity

38.82%

Price to Book

-1.32

Revenue and Profits:

Net Sales:

1 Million

(Quarterly Results - Sep 2025)

Net Profit:

-1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

20.0%

6 Months

-28.0%

1 Year

-41.94%

2 Years

-55.0%

3 Years

-81.25%

4 Years

-94.48%

5 Years

-88.0%

PharmaCielo Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

5.19%

EBIT Growth (5y)

13.16%

EBIT to Interest (avg)

-16.18

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-2.71

Sales to Capital Employed (avg)

0.28

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.20%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-1.12

EV to EBIT

-6.26

EV to EBITDA

-8.63

EV to Capital Employed

2.24

EV to Sales

8.28

PEG Ratio

Dividend Yield

ROCE (Latest)

-35.81%

ROE (Latest)

Negative BV

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bearish

Bollinger Bands

Mildly Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.2%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 200.00% vs -62.50% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -7.69% vs 43.48% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.90",
          "val2": "0.30",
          "chgp": "200.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.30",
          "val2": "-0.50",
          "chgp": "-360.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.90",
          "val2": "0.60",
          "chgp": "50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.20",
          "val2": "-0.10",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.40",
          "val2": "-1.30",
          "chgp": "-7.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,839.10%",
          "val2": "-2,537.90%",
          "chgp": "-30.12%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3.20",
          "val2": "0.00",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.30",
          "val2": "0.00",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "3.40",
          "val2": "0.00",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.10",
          "val2": "0.00",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-9.10",
          "val2": "0.00",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,461.70%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

0.90

0.30

200.00%

Operating Profit (PBDIT) excl Other Income

-2.30

-0.50

-360.00%

Interest

0.90

0.60

50.00%

Exceptional Items

-0.20

-0.10

-100.00%

Consolidate Net Profit

-1.40

-1.30

-7.69%

Operating Profit Margin (Excl OI)

-2,839.10%

-2,537.90%

-30.12%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is 200.00% vs -62.50% in Jun 2025

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is -7.69% vs 43.48% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Change(%)

Net Sales

3.20

0.00

Operating Profit (PBDIT) excl Other Income

-3.30

0.00

Interest

3.40

0.00

Exceptional Items

-1.10

0.00

Consolidate Net Profit

-9.10

0.00

Operating Profit Margin (Excl OI)

-1,461.70%

0.00%

USD in Million.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About PharmaCielo Ltd.

PharmaCielo Ltd.

Other Agricultural Products

Pharmacielo Ltd, formerly AAJ Capital 1 Corp, is a Canada-based company that is engaged in the alternative medicine sector. The Company produces cannabis oils. It offers medicinal-grade oil extracts and related products, which provide relief and wellness formulas for patients in need, including those requiring higher levels of tetrahydrocannabinol (THC). The Company's wholly-owned subsidiary is PharmaCielo Colombia Holdings SAS based in Colombia. The Company works together with Cooperativa Caucannabis and more than 60 local regional farmer members in Cauca, Colombia to cultivate cannabis for the production of standardized, medicinal-grade oil extracts and related products. Pharmacielo Ltd holds Colombian licenses for cannabis.

Company Coordinates

Company Details

82 Richmond St E , TORONTO ON : M5C 1P1

Tel: 1 416 3158741

https://www.pharmacielo.com/

Registrar Details